Raymond James Financial’s Olema Oncology OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$179K Hold
20,700
– – ﹤0.01% 5113
2026
Q2
$259K Buy
20,700
+100
+0.5% +$1.34K ﹤0.01% 4911
2026
Q1
$307K Sell
20,600
-20,047
-49% -$446K ﹤0.01% 4648
2025
Q4
$1.02M Buy
+40,647
New +$723K ﹤0.01% 3759

Other funds holding OLMA

Raymond James Financial's OLMA Position: Q3 2026 in Review

Raymond James Financial held its Olema Oncology (OLMA) position steady in Q3 2026 at 20,700 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #5113.

Raymond James Financial first reported a position in OLMA in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.02M in Q4 2025. 179 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • Raymond James Financial held 20,700 shares of Olema Oncology worth $179K as of Q3 2026.
  • Raymond James Financial left its Olema Oncology share count unchanged in Q3 2026.
  • Olema Oncology made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #5113 holding.
  • Raymond James Financial first reported a position in Olema Oncology in Q4 2025 and has held it in 4 quarters since.
  • Raymond James Financial's Olema Oncology position peaked at $1.02M in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.